ARTICLE | Clinical News
Zeldox ziprasidone dopamine D2 and serotonin 5HT2 receptor antagonist and serotonin receptor agonist regulatory update
January 2, 2001 8:00 AM UTC
PFE said Sweden agreed to delay EU review of its MAA for Zeldox to treat schizophrenia to consider additional data and analyses that also have been submitted to the FDA for review, as well as data fro...